NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Everads Therapy

Everads Therapy

Private
Tel AvivHealthcare & Life Scienceshttps://www.everads-therapy.com/

Last Round

Grant

Feb 1, 2020

Total Funding Raised

$140,000

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Everads Therapy is a biotechnology company developing a novel delivery technology to treat retinal diseases via suprachoroidal administration.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Biotechnology, Clinical Trials, Precision Medicine

Business Model

B2B

Customer Profile

Revenue Share, Services & Consulting, Government Contracts

AI Layer

Non-AI

Keywords

suprachoroidal deliverydrug delivery platformSCS deliveryretinal disease therapyocular drug deliverygene therapy deliverycell therapy deliverynon-surgical deliverydrug delivery licensingmedical device platformsuprachoroidal spaceoffice-based procedureposterior segment deliveryclinical-stage biotech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Everads Therapy Comparables

Compare Everads Therapy with similar companies based on industry and business-model similarity.

Everads Therapy comparables — related companies by embedding similarity
CompanySimilarityMarket Cap

View Full Comparables Set

Access detailed peer comparisons, similarity scores, and market data.

Everads Therapy Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantFeb 1, 2020
AcceleratorJan 1, 2017
View all Funding Rounds

Key People

Founding team and executive leadership

Yonatan Cohavi

Chief Financial Officer

Executive Team

Everads Therapy Investors

Notable investors and investment history

Everads Therapy investors
InvestorRounds
European Innovation CouncilGrant
Israel Innovation AuthorityGrant
RAD BioMedAccelerator
View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 18, 2026

    Monthly visitors grew 36% MoM, from 578 to 785.

  • May 16, 2026

    Monthly visitors increased 47% MoM.

View all signals

Everads Therapy Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Everads Therapy Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Everads Therapy's valuation, stock price, and market status.

Firmographic Details

HeadquartersTel Aviv
Employee Range9
Year Founded2017
Last FundingFeb 1, 2020

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.